Open AccessIdentification of cellular and viral factors related to anti‐hepatitis C virus activity of cyclophilin inhibitor
Author(s) -
Goto Kaku,
Watashi Koichi,
Inoue Daisuke,
Hijikata Makoto,
Shimotohno Kunitada
Publication year - 2009
Publication title -
cancer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.035
H-Index - 141
eISSN - 1349-7006
pISSN - 1347-9032
DOI - 10.1111/j.1349-7006.2009.01263.x
Subject(s) - replicon , biology , cypa , viral replication , ns5a , virology , subgenomic mrna , cyclophilin a , hepatitis c virus , ns5b , peptidylprolyl isomerase , interferon , virus , cyclophilin , rna , microbiology and biotechnology , hepacivirus , genetics , gene , isomerase , plasmid
We have so far reported that an immunosuppressant cyclosporin A (CsA), a well‐known cyclophilin (CyP) inhibitor (CPI), strongly suppressed hepatitis C virus (HCV) replication in cell culture, and that CyPB was a cellular cofactor for viral replication. To further investigate antiviral mechanisms of CPI, we here developed cells carrying CsA‐resistant HCV replicons, by culturing the HCV subgenomic replicon cells for 4 weeks in the presence of CsA with G418. Transfection of total RNA from the isolated CsA‐resistant cells to naïve Huh7 cells conferred CsA resistance, suggesting that the replicon RNA itself was responsible for the resistant phenotype. Of the identified amino acid mutations, D320E in NS5A conferred the CsA resistance. The replicon carrying the D320E mutation was sensitive to interferon‐α, but was resistant to CsA and other CPIs including NIM811 and sanglifehrin A. Knockdown of individual CyP subtypes revealed CyP40, in addition to CyPA and CyPB, contributed to viral replication, and CsA‐resistant replicons acquired independence from CyPA for efficient replication. These data provide important evidence on the mechanisms underlying the regulation of HCV replication by CyP and for designing novel and specific anti‐HCV strategies with CPIs. ( Cancer Sci 2009; 100: 1943–1950)